Grant: Operating Grant: Joint Programme on Neurodegenerative Disease Research (JPND)
McGill University
$344,270.00
Diagnostic and prognostic precision medicine for behavioral variant frontotemporal dementia
FY 2019-20
Summary
The behavioral variant of frontotemporal dementia (bvFTD) is a common cause of early-onset dementia (before age 65) with a lot of different variations in underlying pathology, genetics, and natural course. It therefore demands a customized approach to predict individual prognosis and develop personalized treatments. BvFTD is often mistaken for a primary psychiatric disorder (PPD), causing substantial diagnostic delay up to 6 years in average. Therefore, the most time critical clinical challenge is how to differentiate early bvFTD (in majority non-genetic) from late-onset psychiatric disorders that may mimic FTD, in order to deliver relevant interventions and treatments.
All members of our multidisciplinary consortium have a strong track record in bvFTD research. We selected the most promising results of our ongoing research, including neuropsychological and social cognitive markers; neuroimaging- based classifiers; cerebrospinal fluid and serum biomarkers; and genetic makers. In this project, we will combined cohorts from all sites to examine and validate the above-mentioned markers (discovery cohort). This includes a large number of autopsy confirmed cases. We will then validate these markers in a deeply phenotyped prospective multi-national cohort that we will collect over the next 3 years. We will use advanced statistics to create the best diagnostic and prognostic models for bvFTD and PPD. Our project will contribute towards an early and accurate bvFTD identification, that is crucial for trial enrollment, whereas on the other hand early PPD identification will lead to the appropriate psychiatric treatments.
Department
Program
Operating Grant: Joint Programme on Neurodegenerative Disease Research (JPND)
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
407000
Name
Ducharme Simon
Region
Québec
Country
Canada
Orgtype
Research Institution; Institution Paid
Partnername
German Federal Ministry of Research, Technology and Space (Berlin); Ministry of Education, Universities and Research (Rome); National Health and Medical Research Council of Australia; The Netherlands Organization for Health Research and Development (ZonMw)
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Special Cases
Projecttitle
Diagnostic and prognostic precision medicine for behavioral variant frontotemporal dementia
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$344,270
Cihrequipment2
$0
Programname2
Operating Grant: Joint Programme on Neurodegenerative Disease Research (JPND)
Keyworddelim
Frontotemporal Dementia; Multivariate Statistics; Neuroimaging; Neuron-Derived Cell Free Dna Methylation; Precision Medicine; Psychiatry
Abstract
The behavioral variant of frontotemporal dementia (bvFTD) is a common cause of early-onset dementia (before age 65) with a lot of different variations in underlying pathology, genetics, and natural course. It therefore demands a customized approach to predict individual prognosis and develop personalized treatments. BvFTD is often mistaken for a primary psychiatric disorder (PPD), causing substantial diagnostic delay up to 6 years in average. Therefore, the most time critical clinical challenge is how to differentiate early bvFTD (in majority non-genetic) from late-onset psychiatric disorders that may mimic FTD, in order to deliver relevant interventions and treatments.
All members of our multidisciplinary consortium have a strong track record in bvFTD research. We selected the most promising results of our ongoing research, including neuropsychological and social cognitive markers; neuroimaging- based classifiers; cerebrospinal fluid and serum biomarkers; and genetic makers. In this project, we will combined cohorts from all sites to examine and validate the above-mentioned markers (discovery cohort). This includes a large number of autopsy confirmed cases. We will then validate these markers in a deeply phenotyped prospective multi-national cohort that we will collect over the next 3 years. We will use advanced statistics to create the best diagnostic and prognostic models for bvFTD and PPD. Our project will contribute towards an early and accurate bvFTD identification, that is crucial for trial enrollment, whereas on the other hand early PPD identification will lead to the appropriate psychiatric treatments.
Competitiondate
201906
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Ducharme, Simon
Approvedterm
3 ans 0 mois
Cihrcontribution2
Institute of Aging~ $344,270~ $0~